161 related articles for article (PubMed ID: 2858057)
1. Location of neuronal tangles in somatostatin neurones in Alzheimer's disease.
Roberts GW; Crow TJ; Polak JM
Nature; 1985 Mar 7-13; 314(6006):92-4. PubMed ID: 2858057
[TBL] [Abstract][Full Text] [Related]
2. Somatostatin immunoreactivity in neuritic plaques of Alzheimer's patients.
Morrison JH; Rogers J; Scherr S; Benoit R; Bloom FE
Nature; 1985 Mar 7-13; 314(6006):90-2. PubMed ID: 2858056
[TBL] [Abstract][Full Text] [Related]
3. [Pathophysiology of senile dementia].
Karobath M
Schweiz Med Wochenschr; 1985 Dec; 115(50):1803-7. PubMed ID: 2868521
[TBL] [Abstract][Full Text] [Related]
4. Reduced somatostatin-like immunoreactivity in cerebral cortex from cases of Alzheimer disease and Alzheimer senile dementa.
Davies P; Katzman R; Terry RD
Nature; 1980 Nov; 288(5788):279-80. PubMed ID: 6107862
[TBL] [Abstract][Full Text] [Related]
5. Somatostatin- and neuropeptide Y-immunoreactive neurons in the neocortex in senile dementia of Alzheimer's type.
Nakamura S; Vincent SR
Brain Res; 1986 Apr; 370(1):11-20. PubMed ID: 2871890
[TBL] [Abstract][Full Text] [Related]
6. Somatostatin immunoreactive neurons in the human hippocampus and cortex shown by immunogold/silver intensification on vibratome sections: coexistence with neuropeptide Y neurons, and effects in Alzheimer-type dementia.
Chan-Palay V
J Comp Neurol; 1987 Jun; 260(2):201-23. PubMed ID: 2886516
[TBL] [Abstract][Full Text] [Related]
7. Critical role of somatostatin receptor 2 in the vulnerability of the central noradrenergic system: new aspects on Alzheimer's disease.
Ádori C; Glück L; Barde S; Yoshitake T; Kovacs GG; Mulder J; Maglóczky Z; Havas L; Bölcskei K; Mitsios N; Uhlén M; Szolcsányi J; Kehr J; Rönnbäck A; Schwartz T; Rehfeld JF; Harkany T; Palkovits M; Schulz S; Hökfelt T
Acta Neuropathol; 2015 Apr; 129(4):541-63. PubMed ID: 25676386
[TBL] [Abstract][Full Text] [Related]
8. Decreased somatostatin immunoreactivity but not neuropeptide Y immunoreactivity in cerebral cortex in senile dementia of Alzheimer type.
Dawbarn D; Rossor MN; Mountjoy CQ; Roth M; Emson PC
Neurosci Lett; 1986 Sep; 70(1):154-9. PubMed ID: 2877420
[TBL] [Abstract][Full Text] [Related]
9. Reciprocal changes in corticotropin-releasing factor (CRF)-like immunoreactivity and CRF receptors in cerebral cortex of Alzheimer's disease.
De Souza EB; Whitehouse PJ; Kuhar MJ; Price DL; Vale WW
Nature; 1986 Feb 13-19; 319(6054):593-5. PubMed ID: 3003585
[TBL] [Abstract][Full Text] [Related]
10. Cortical somatostatin, neuropeptide Y, and NADPH diaphorase neurons: normal anatomy and alterations in Alzheimer's disease.
Kowall NW; Beal MF
Ann Neurol; 1988 Feb; 23(2):105-14. PubMed ID: 2897822
[TBL] [Abstract][Full Text] [Related]
11. [Neurotransmitter anomalies in Alzheimer's disease].
Berger B
Rev Neurol (Paris); 1984; 140(10):539-52. PubMed ID: 6150545
[TBL] [Abstract][Full Text] [Related]
12. Some morphometric observations on the cerebral cortex and hippocampus in presenile Alzheimer's disease, senile dementia of Alzheimer type and Down's syndrome in middle age.
Mann DM; Yates PO; Marcyniuk B
J Neurol Sci; 1985 Jul; 69(3):139-59. PubMed ID: 3162000
[TBL] [Abstract][Full Text] [Related]
13. A quantitative assessment of somatostatin-like and neuropeptide Y-like immunostained cells in the frontal and temporal cortex of patients with Alzheimer's disease.
Davies CA; Morroll DR; Prinja D; Mann DM; Gibbs A
J Neurol Sci; 1990 Apr; 96(1):59-73. PubMed ID: 1972185
[TBL] [Abstract][Full Text] [Related]
14. Some enkephalin- or VIP-immunoreactive hippocampal pyramidal cells contain neurofibrillary tangles in the brains of aged humans and persons with Alzheimer's disease.
Kulmala HK
Neurochem Pathol; 1985; 3(1):41-51. PubMed ID: 2410823
[TBL] [Abstract][Full Text] [Related]
15. A post-mortem comparison of the cortical cholinergic system in Alzheimer's disease and Pick's disease.
Wood PL; Etienne P; Lal S; Nair NP; Finlayson MH; Gauthier S; Palo J; Haltia M; Paetau A; Bird ED
J Neurol Sci; 1983 Dec; 62(1-3):211-7. PubMed ID: 6142096
[TBL] [Abstract][Full Text] [Related]
16. The second layer neurones of the entorhinal cortex and the perforant path in physiological ageing and Alzheimer's disease.
Moryś J; Sadowski M; Barcikowska M; Maciejewska B; Narkiewicz O
Acta Neurobiol Exp (Wars); 1994; 54(1):47-53. PubMed ID: 8023713
[TBL] [Abstract][Full Text] [Related]
17. Advanced glycation end products in Alzheimer's disease and other neurodegenerative diseases.
Sasaki N; Fukatsu R; Tsuzuki K; Hayashi Y; Yoshida T; Fujii N; Koike T; Wakayama I; Yanagihara R; Garruto R; Amano N; Makita Z
Am J Pathol; 1998 Oct; 153(4):1149-55. PubMed ID: 9777946
[TBL] [Abstract][Full Text] [Related]
18. Cortical somatostatinergic system not affected in Alzheimer's and Parkinson's diseases.
Whitford C; Candy J; Edwardson J; Perry R
J Neurol Sci; 1988 Aug; 86(1):13-8. PubMed ID: 2902199
[TBL] [Abstract][Full Text] [Related]
19. Alzheimer's disease: low cerebral somatostatin levels correlate with impaired cognitive function and cortical metabolism.
Tamminga CA; Foster NL; Fedio P; Bird ED; Chase TN
Neurology; 1987 Jan; 37(1):161-5. PubMed ID: 2879258
[TBL] [Abstract][Full Text] [Related]
20. [Alzheimer's type dementia: recent data].
Lamour Y; Davous P
Presse Med; 1983 May; 12(22):1415-20. PubMed ID: 6134279
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
